222 related articles for article (PubMed ID: 11514985)
1. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons.
Strömberg I; Törnqvist N; Johansson S; Bygdeman M; Almqvist PM
Microsc Res Tech; 2001 Sep; 54(5):287-97. PubMed ID: 11514985
[TBL] [Abstract][Full Text] [Related]
2. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
3. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
Yurek DM
Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
[TBL] [Abstract][Full Text] [Related]
4. Locus coeruleus promotes survival of dopamine neurons in ventral mesencephalon. An in oculo grafting study.
Berglöf E; Strömberg I
Exp Neurol; 2009 Mar; 216(1):158-65. PubMed ID: 19150447
[TBL] [Abstract][Full Text] [Related]
5. Target-specific outgrowth from human mesencephalic tissue grafted to cortex or ventricle of immunosuppressed rats.
Strömberg I; Bygdeman M; Almqvist P
J Comp Neurol; 1992 Jan; 315(4):445-56. PubMed ID: 1348513
[TBL] [Abstract][Full Text] [Related]
6. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
7. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
[TBL] [Abstract][Full Text] [Related]
8. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
9. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons.
Yurek DM; Lu W; Hipkens S; Wiegand SJ
Exp Neurol; 1996 Jan; 137(1):105-18. PubMed ID: 8566202
[TBL] [Abstract][Full Text] [Related]
10. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
11. Human fetal neocortical tissue grafted to rat brain cavities survives, leads to reciprocal nerve fiber growth, and accumulates host IgG.
Humpel C; Bygdeman M; Olson L; Strömberg I
J Comp Neurol; 1994 Feb; 340(3):337-48. PubMed ID: 7910615
[TBL] [Abstract][Full Text] [Related]
12. Co-grafts of fetal ventral mesencephalon and fibroblasts expressing sonic hedgehog: effect on survival and function of dopamine grafts.
Yurek DM; Fletcher-Turner A; Moore J; Chai L; Mahanthappa N
Cell Transplant; 2001; 10(8):665-71. PubMed ID: 11814108
[TBL] [Abstract][Full Text] [Related]
13. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
14. [Fate of human fetal dopamine neurons transplanted into rhesus monkey model of Parkinson's disease: a tyrosine hydroxylase immunocytochemical study].
Jiang ZH; Liu ZG; Chen SD; Zhou WB; Cai J; Ni ZM; Zhou CF
Sheng Li Xue Bao; 1995 Feb; 47(1):31-7. PubMed ID: 7784896
[TBL] [Abstract][Full Text] [Related]
15. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
17. Fetal dopaminergic neurons transplanted to the normal striatum of neonatal or adult rats and to the denervated striatum of adult rats.
Sable V; Sailaja K; Gopinath G; Tandon PN
J Neural Transplant Plast; 1997; 6(2):73-81. PubMed ID: 9306239
[TBL] [Abstract][Full Text] [Related]
18. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
19. Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys.
Elsworth JD; Sladek JR; Taylor JR; Collier TJ; Redmond DE; Roth RH
Neuroscience; 1996 May; 72(2):477-84. PubMed ID: 8737417
[TBL] [Abstract][Full Text] [Related]
20. Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats.
Fitzpatrick E; Ashkan K; Wallace BA; Benabid AL; Mitrofanis J
Anat Embryol (Berl); 2005 Sep; 210(2):101-23. PubMed ID: 16151853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]